Shivram, Haridha http://orcid.org/0000-0001-5897-8288
Cress, Brady F. http://orcid.org/0000-0002-2948-2846
Knott, Gavin J.
Doudna, Jennifer A. http://orcid.org/0000-0001-9161-999X
Funding for this research was provided by:
United States Department of Defense | Defense Advanced Research Projects Agency (HR0011- 17-2-0043, HR0011- 17-2-0043)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (F32 GM131654)
Department of Health | National Health and Medical Research Council (1175568)
Article History
Received: 1 July 2020
Accepted: 22 October 2020
First Online: 16 December 2020
Competing interests
: The Regents of the University of California have patents issued and pending for CRISPR technologies on which H.S., B.F.C., G.J.K. and J.A.D. are inventors. J.A.D. is a cofounder of Caribou Biosciences, Editas Medicine, Scribe Therapeutics, Intellia Therapeutics and Mammoth Biosciences. J.A.D. is a scientific advisory board member of Caribou Biosciences, Intellia Therapeutics, eFFECTOR Therapeutics, Scribe Therapeutics, Mammoth Biosciences, Synthego, Algen Biotechnologies, Felix Biosciences and Inari. J.A.D. is a Director at Johnson & Johnson and has research projects sponsored by Biogen, Pfizer, AppleTree Partners and Roche.